Quotidian dialysis - Update 2005

Current Opinion in Nephrology and Hypertension

Volumn 14, Issue 2, 2005, Pages 119-124

  Pierratos, Andreas ^a,d   McFarlane, Phil ^b   Chan, Christopher T ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d HUMBER RIVER REGIONAL HOSPITAL   (Canada)

Author keywords

Daily hemodialysis; Home hemodialysis; Noctumal hemodialysis

Indexed keywords

CARDIOVASCULAR AGENT; ERYTHROPOIETIN; PHOSPHATE BINDING AGENT;

ACUTE KIDNEY FAILURE; ANEMIA; BONE DISEASE; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEMODIALYSIS; HOME DIALYSIS; HOSPITALIZATION; HUMAN; INFECTION; MEDICAID; MEDICARE; NUTRITION; PATIENT SELECTION; PHOSPHATE METABOLISM; PRIORITY JOURNAL; QUALITY OF LIFE; REGISTER; REIMBURSEMENT; REVIEW; SOLUTE; THROMBOSIS; TRAINING; TREATMENT OUTCOME; VASCULAR ACCESS;

EID: 15444375817     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200503000-00006     Document Type: Review

References (73)

1. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-2019.
2. Pierratos A. New approaches to hemodialysis. Annu Rev Med 2004; 55:179-189.
3. Maduell F, Navarro V, Torregrosa E, et al. Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int 2003; 64:305-313. The first clinical results on in-center short daily hemodiafiltration.
4. Zimmerman DL. Hemofiltration as a treatment for end-stage renal disease. Hemodial Int 2004; 8:183-187. Review of hemofiltration with an emphasis on short daily home treatment.
5. Pierratos A. Daily hemodialysis: an update. Curr Opin Nephrol Hypertens 2002; 11:165-171. Our previous review including the older references.
6. Ledebo I, Fredin R. The Gambro system for home daily dialysis. Semin Dial 2004; 17:162-163.
7. Kjellstrand CM, Blagg CR, Bower J, Twardowski ZJ. The AKSYS personal hemodialysis system. Semin Dial 2004; 17:151-153.
8. Kelly TD. Baxter Aurora dialysis system. Semin Dial 2004; 17:154-155.
9. Schlaeper C, Diaz-Buxo JA. The Fresenius Medical Care home hemodialysis system. Semin Dial 2004; 17:159-161.
10. Ash SR. The Allient Dialysis System. Semin Dial 2004; 17:164-166.
11. Trewin E. Bellco Formula Domus Home Care System. Semin Dial 2004; 17:156-158.
12. Clark WR, Turk JE. The NxStage System One. Semin Dial 2004; 17:167-170.
13. Hoy C. Remote monitoring in nocturnal home hemodialysis 2003. Hemodial Int 2004; 8:144-150. Detailed review of remote monitoring for nocturnal hemodialysis.
14. Heidenheim AP, Leitch R, Kortas C, Lindsay RM. Patient monitoring in the London daily/nocturnal hemodialysis study. Am J Kidney Dis 2003; 42:61-65. Experience with monitoring of patients on nocturnal hemodialysis.
15. Halpern SD, Berns JS, Israni AK. Willingness of patients to switch from conventional to daily hemodialysis: looking before we leap. Am J Med 2004; 116:606-612.
16. Ting GO, Kjellstrand C, Freitas T, et al. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 2003; 42:1020-1035. Using in-center short daily hemodialysis as a rescue therapy.
17. Lockridge RS Jr, Spencer MO, Craft VW, et al. 6 Years of experience with nightly home hemodialysis access. Hemodial Int 2004; 8:79.
18. Twardowski ZJ. Blood access in daily hemodialysis. Hemodial Int 2004; 8: 70-76. Very useful review of the topic of vascular access.
19. Piccoli GB, Bermond F, Mezza E, et al. Vascular access survival and morbidity on daily dialysis: a comparative analysis of home and limited care haemodialysis. Nephrol Dial Transplant 2004; 19:2084-2094. Retrospective analysis of the access experience on daily hemodialysis.
20. Gotch FA. Definitions of dialysis dose suitable for comparison of daily hemodialysis and continuous ambulatory peritoneal dialysis to conventional thrice weekly dialysis therapy. Hemodial Int 2004; 8:172-182. Treatise on the issue of the preferable measure of dialysis dose with special reference to daily hemodialysis.
21. Depner TA, Bhat A. Quantifying daily hemodialysis. Semin Dial 2004; 17: 79-84. Evaluating the approach to quantitation of daily hemodialysis dose.
22. Leypoldt JK, Jaber BL, Lysaght MJ, et al. Kinetics and dosing predictions for daily haemofiltration. Nephrol Dial Transplant 2003; 18:769-776. Comparison of kinetics of daily hemofiltration to different hemodialysis schedules.
23. Suri R, Depner TA, Blake PG, et al. Adequacy of quotidian hemodialysis. Am J Kidney Dis 2003; 42:42-48. The London, Ontario study: urea kinetics.
24. Williams AW, Chebrolu SB, Ing TS, et al. Early clinical, quality-of-life, and biochemical changes of "daily hemodialysis" (6 dialyses per week). Am J Kidney Dis 2004; 43:90-102. Comparison of the short-term results from short daily hemodialysis with those from conventional hemodialysis.
25. Leypoldt JK, Jaber BL, Zimmerman DL. Predicting treatment dose for novel therapies using urea standard kt/v. Semin Dial 2004; 17:142-145.
26. Spanner E, Suri R, Heidenheim AP, Lindsay RM. The impact of quotidian hemodialysis on nutrition. Am J Kidney Dis 2003; 42:30-35. The London, Ontatio study: nutrition.
27. Heidenheim AP, Muirhead N, Moist L, Lindsay RM. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 2003; 42:36-41. The London, Ontario study: quality of life.
28. Lockridge RS, Spencer M, Craft V, et al. Nightly home hemodialysis: Five and one-half years of experience in Lynchburg, Virginia. Hemodial Int 2004; 8:61-69. The longest experience on nocturnal hemodialysis in the USA.
29. Kooistra MP, Vos J, Koomans HA, Vos PF. Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 1998; 13:2853-2860.
30. Pierratos A. Daily nocturnal home hemodialysis. Kidney Int 2004; 65: 1975-1986. Review of the topic of daily nocturnal hemodialysis.
31. Mohr PE, Neumann PJ, Franco SJ, et al. The case for daily dialysis: its impact on costs and quality of life. Am J Kidney Dis 2001; 37:777-789.
32. Reynolds JT, Homel P, Cantey L, et al. A one-year trial of in-center daily hemodialysis with an emphasis on quality of life. Blood Purif 2004; 22: 320-328. Quality of life on short daily hemodialysis.
33. McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int 2003; 64:1004-1011. Increased cost utility of nocturnal hemodialysis.
34. Gutzwiller JP, Schneditz D, Huber AR, et al. Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis dose. Nephrol Dial Transplant 2002; 17:1037-1044.
35. Gotch FA, Panlilio F, Sergeyeva O, et al. A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy. Blood Purif 2003; 21:51-57.
36. Galland R, Traeger J, Delawari E, Arkouche W. Optimal control of phosphatemia by short daily hemodialysis. Hemodial Int 2003; 7:73-104. Effect of short daily hemodialysis on phosphate removal. Effect of increased protein intake.
37. Kim SJ, Goldstein M, Szabo T, Pierratos A. Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis. Am J Kidney Dis 2003; 41:12.
38. Al Hejaili F, Kortas C, Leitch R, et al. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 2003; 14:2322-2328.
39. Traeger J, Galland R, Delawari E, et al. Six years' experience with short daily hemodialysis: Do the early improvements persist in the mid and long term? Hemodial Int 2004; 8:151-158. Long-term effect of short daily hemodialysis on nutrition.
40. Agar JWM, Somerville CA, Dwyer KM, et al. Nocturnal hemodialysis in Australia. Hemodial Int 2003; 7:278-289.
41. Geary DF, Piva E, Gajaria M, et al. Development of a nocturnal home hemodialysis (NHHD) program for children. Semin Dial 2004; 17:115-117.
42. Fischbach M, Terzic J, Laugel V, et al. Daily on-line haemodiafiltration: a pilot trial in children. Nephrol Dial Transplant 2004; 19:2360-2367.
43. Fagugli RM, Pasini P, Quintaliani G, et al. Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients. Nephrol Dial Transplant 2003; 18:2332-2338. Decreased extracellular water correlates with blood pressure control and regression of cardiac mass.
44. Nesrallah G, Suri R, Moist L, et al. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 2003; 42:13-17. Relationship between volume control and blood pressure is different on short daily hemodialysis compared to nocturnal hemodialysis.
45. Chan CT, Harvey PJ, Picton P, et al. Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 2003; 42:925-931. Nocturnal hemodialysis causes vasodilation and improves endothelial function.
46. Chan CT, Floras JS, Miller JA, et al. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002; 61:2235-2239.
47. Chan C, Floras JS, Miller JA, Pierratos A. Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 2002; 17:1518-1521.
48. Chan CT, Hanly P, Gabor J, et al. Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int 2004; 65:661-665. Nocturnal hemodialysis increases heart rate variability (predictor of cardiac arrhythmias) during sleep.
49. Hanly PJ, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001; 344:102-107.
50. Chan CT, Mardirossian S, Faratro R, Richardson RM. Improvement in lower-extremity peripheral arterial disease by nocturnal hemodialysis. Am J Kidney Dis 2003; 41:225-229.
51. Bugeja AL, Chan CT. Improvement in lipid profile by nocturnal hemodialysis in patients with end-stage renal disease. ASAIO J 2004; 50:328-331.
52. McCormick BB, Pierratos A, Fenton S, et al. Review of clinical outcomes in nocturnal haemodialysis patients after renal transplantation. Nephrol Dial Transplant 2004; 19:714-719.
53. Chan CT, Harvey PJ, Pierratos A, et al. Importance of phosphate control for restoration of vascular responsiveness in end-stage renal disease patients converted to nocturnal hemodialysis. Hemodial Int 2004; 8:91. Serum phosphate on conventional hemodialysis correlates with the speed of recovery of endothelial function after conversion to quotidian nocturnal hemodialysis.
54. Yuen D, Pierratos A, Chan C. Nocturnal hemodialysis results in stable coronary calcification as measured by helical computed tomography in patients with end stage renal disease. J Am Soc Nephrol 2004; 15:188A. Nocturnal hemodialysis may arrest coronary artery calcification.
55. de Groot K, Hermann Bahlmann F, Sowa J, et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004; 66:641-646. Renal patients have deficiency of the endothelial stem cell number and function which have been found to correlate with cardiac events.
56. Chan CT, Li SH, Verma S. Restoration of number and function of endothelial progenitor cells by nocturnal hemodialysis is associated with normal left ventricular geometry in dialysis patients. J Am Soc Nephrol 2004; 15:614A. Nocturnal hemodialysis restores the vascular endothelial stem cells to normal.
57. Rao M, Muirhead N, Klarenbach S, et al. Management of anemia with quotidian hemodialysis. Am J Kidney Dis 2003; 42:18-23.
58. Pierratos A, Ouwendyk M, Francoeur R, et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 1998; 9:859-868.
59. Schwartz D, Pierratos A, Richardson RMA, et al. Impact of nocturnal home hemodialysis on anemia management in patients with end-stage renal disease. Clin Nephrol 2004 (in press).
60. Ly J, Marticorena R, Donnelly S. Red blood cell survival in chronic renal failure. Am J Kidney Dis 2004; 44:715-719.
61. Hanly PJ, Gabor JY, Chan C, Pierratos A. Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis. Am J Kidney Dis 2003; 41:403-410. Daytime sleepiness is prevalent in the dialysis population. Nocturnal hemodialysis does not improve it.
62. Woods JD, Port FK, Orzol S, et al. Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int 1999; 55:2467-2476.
63. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346:305-310.
64. Nesrallah GE, Moist LM, Awaraji C, Lindsay RM. An international registry to compare quotidian dialysis regimens with conventional thrice-weekly hemodialysis: why, how, and potential pitfalls. Semin Dial 2004; 17:131-135.
65. Briggs JP. Evidence-based medicine in the Dialysis Unit: a few lessons from the USRDS and the NCDS and HEMO trials. Semin Dial 2004; 17:136-141.
66. McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int 2002; 62:2216-2222.
67. Bergman A, Fenton S, Richardson RM, Chan CT. Reduction in hospitalizations with nocturnal hemodialysis. J Am Soc Nephrol 2004; 15:188A.
68. Hou S. Daily dialysis in pregnancy. Hemodial Int 2004; 8:167-171. Review of the beneficial treatment of daily hemodialysis of more than 4 h.
69. Kroeker A, Clark WF, Heidenheim AP, et al. An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis 2003; 42:49-55. The London, Ontario study: quotidian hemodialysis costs less than conventional hemodialysis.
70. Lindsay RM, Leitch R, Heidenheim AP, Kortas C. The London daily/nocturnal hemodialysis study - study design, morbidity, and mortality results. Am J Kidney Dis 2003; 42:5-12. The London Ontario study.
71. Lindsay RM, Alhejaili F, Nesrallah G, et al. Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 2003; 42:S24-S29.
72. McFarlane PA. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada. Semin Dial 2004; 17:118-124. Useful comparison of the costing studies of the different hemodialysis schedules.
73. Buoncristiani U. Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 1998; 13(suppl 6):148-151.